MNV
Market News Video
MNV MNV 10 Stocks Crossing Below Book Value
MNV
MNV
MNV
MNV
MNV
MNV
MNV
Free Dividend Report - Top Ranked Stocks

Featured MNV Articles:

Analysts Anticipate XPH To Hit $62
Tuesday, October 27, 8:08 AM ET, by Market News Video Staff

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, ...

BioDelivery Sciences International (BDSI) Shares Cross Above 200 DMA
Monday, December 7, 11:28 AM ET, by Market News Video Staff

In trading on Monday, shares of BioDelivery Sciences International Inc (BDSI) crossed above their 200 ...

The Implied Analyst 12-Month Target For XPH
Tuesday, December 22, 8:38 AM ET, by Market News Video Staff

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, ...

Sum Up The Pieces: XPH Could Be Worth $67
Friday, January 22, 7:48 AM ET, by Market News Video Staff

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, ...

BioDelivery Sciences International Breaks Above 200-Day Moving Average - Bullish for BDSI
Tuesday, February 16, 11:31 AM ET, by Market News Video Staff

In trading on Tuesday, shares of BioDelivery Sciences International Inc (BDSI) crossed above their 200 ...

Top Buys by Directors: Kotler's $960.5K Bet on BDSI

By Market News Video Staff, Monday, May 17, 1:40 PM ET
Play Video: One Reason For Insiders to Buy


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Email EnvelopeFree Email Alerts By Stock:
Get Dividend Alerts
Get SEC Filing Alerts

The directors of a company tend to have a unique inside view into the business, so when directors make major buys, investors are wise to take notice. Presumably the only reason a director of a company would choose to take their hard-earned cash and use it to buy stock in the open market, is that they expect to make money — maybe they find the stock very undervalued, or maybe they see exciting progress within the company, or maybe both. So in this series we look at the largest insider buys by company directors over the trailing six month period, one of which was a total of $960.5K by Kevin Kotler, Director at BioDelivery Sciences International Inc (NASDAQ:BDSI).

Kotler bets big on BDSI:

Purchased Insider Title Shares Price/Share Value
05/13/2021 Kevin Kotler Director 300,000 $3.20 $960,500.00

Kotler's average cost works out to $3.20/share. Shares of BioDelivery Sciences International Inc were changing hands at $3.69 at last check, trading up about 3.9% on Monday. The chart below shows the one year performance of BDSI shares, versus its 200 day moving average:

BioDelivery Sciences International Inc Chart

Looking at the chart above, BDSI's low point in its 52 week range is $3.04 per share, with $5.45 as the 52 week high point — that compares with a last trade of $3.69.


Special Offer: Join the income investing conversation on ValueForum.com with a special Seven Days for Seven Dollars invitation.


This Article's Word Cloud:   BDSI   BioDelivery   Buys   Company   Days   Director   Directors   Dollars   Insider   International   Join   Kevin   Kotler   Looking   Monday   Offer   Presumably   Price   Purchased   Sciences   Seven   Share   Shares   Special   Start   Title   Value   ValueForum   about   above   average   below   bets   both   buys   chart   company   directors   last   make   maybe   mdash   point   share   stock   take   that   they   week   with
MNV
MNV
About Us - Advertise - Contact Us - Embedding Videos - Licensing Videos - Partners - mRSS / RSS Feed - Terms of Use - Privacy Policy
MNV
Home  |  Analyst News  Dividend Report  ETFs  Insider Report  Large Caps  Market Movers  Week Ahead Report  Weekly Market Wrap
MNV
MNV MNV Stock Message Boards Stock Market Definitions
MNV

Top Buys by Directors: Kotler's $960.5K Bet on BDSI | Market News Video | Copyright © 2008 - 2021, All Rights Reserved

Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners. In no way should any content contained herein be interpreted to represent trading or investment advice. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.